Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world.

What happens when a patient’s only treatment hope rests with a promising but not yet locally approved therapy? At Novartis, we are providing a lifeline of access to innovative medicines under review or not yet approved locally when no other treatment options are available.

Novartis researchers are using new technologies, such as DNA-encoded libraries, to find new ways to treat disease.

We’re working to bring the hope of advanced medicine to more patients.

Groups of people doing communal exercises are an everyday sight in Japan, but for one woman they are a very public way to show she is fighting back.

Novartis worked with doctors, patients and government officials in the Yaroslavl region of Russia to address high death rates from stroke and heart disease.

We leave the lab to find out what people know about cell and gene therapy.